The Government is waiting for the European Commission’s green light to grant a state aid to Cantacuzino Institute, by writing off all the institution’s debts, PM Victor Ponta informed on Wednesday. He also said a plan must be drafted preventing the institute from accumulating more debts after this moment.
“We have the ordinance draft granting a state aid to Cantacuzino National Research Institute. So, we have to write off all debts and start from a T0 moment. It’s important we have a plan against new debts so that the institute should be set on track and carry out its national strategic role,” the premier said.
Cantacuzino Institute’s employees have repeatedly protested against the situation and the dissolution of the institution, even asking for the President’s involvement. Manager Adrian Onu resigned from the helm of the institute in early March, arguing the authorities haven’t supported him to snatch the institute out of fire.
A month ago, during a visit to the institute, president Klaus Iohannis pledged to lobby for solving the institute’s complicated situation, even by debating the issue within the Supreme Council of National Defense (CSAT).
Cantacuzino National Institute of Research-Development for Microbiology and Immunology (CNIR) is a national institute in Romania, which does scientific research in the fields of microbiology, immunology, molecular biology and genetics, and education of microbiology, immunology, epidemiology, training of scientific and technical. Despite ranking among the most appreciated immunological producers in the world, the institute has started to face decline since February 2010, after the National Agency of Medicines withdrew its authorization to sell products for injection, including vaccines, as the fabrication standard had expired. Under these conditions, some immunization national programs have been blocked for several months, while the authorities being compelled to import other vaccines.
Media and civil society have long blamed the state authorities of closing their eyes or even of being hand in hand with the foreign drug companies that would want their medicine and vaccines prevail on the Romanian market.